Big Partnerships Give Biotechs A Boost To Richer Exits
This article was originally published in Start Up
Executive Summary
Biotechs in recent years are more likely to fetch a higher acquisition price – practically the only way for investors to exit these days – if the company has previously signed a major alliance. But the partners aren't necessarily the ones buying.